2.2 Pharmacokinetics and Pharmacodynamics
3 min read•june 18, 2024
Drugs interact with our bodies in complex ways, affecting cells, enzymes, and ion channels. Understanding these interactions helps us grasp how medications work and why they sometimes cause . explores the intricate dance between drugs and our body's systems.
looks at how our bodies process drugs over time. From to elimination, many factors influence a drug's effectiveness. , , and potential for or all play crucial roles in determining how we use medications safely and effectively.
Pharmacodynamics
Drug interactions with body cells
Top images from around the web for Drug interactions with body cells
Frontiers | Calcium Permeable Channels in Cancer Hallmarks View original
Is this image relevant?
1.2 Kinetics and Dynamics – Nursing Pharmacology View original
Is this image relevant?
Frontiers | Molecular Interplay Between the Sigma-1 Receptor, Steroids, and Ion Channels View original
Is this image relevant?
Frontiers | Calcium Permeable Channels in Cancer Hallmarks View original
Is this image relevant?
1.2 Kinetics and Dynamics – Nursing Pharmacology View original
Is this image relevant?
1 of 3
Top images from around the web for Drug interactions with body cells
Frontiers | Calcium Permeable Channels in Cancer Hallmarks View original
Is this image relevant?
1.2 Kinetics and Dynamics – Nursing Pharmacology View original
Is this image relevant?
Frontiers | Molecular Interplay Between the Sigma-1 Receptor, Steroids, and Ion Channels View original
Is this image relevant?
Frontiers | Calcium Permeable Channels in Cancer Hallmarks View original
Is this image relevant?
1.2 Kinetics and Dynamics – Nursing Pharmacology View original
Is this image relevant?
1 of 3
- Drugs bind to specific receptors on cell surfaces or within cells
- activate receptors to produce a response ( activates opioid receptors)
- block receptors, preventing activation ( blocks opioid receptors)
- determines the strength of drug- binding
- Some drugs act by inhibiting or enhancing enzyme activity
- block the of enzymes, reducing the production of specific substances ( inhibit HMG-CoA reductase)
- increase the activity of enzymes, enhancing the production of specific substances ( induces enzymes)
- Certain drugs interact with ion channels, altering the flow of ions across cell membranes
- block ion channels, reducing the flow of ions (calcium channel blockers)
- open ion channels, increasing the flow of ions (potassium channel openers)
- Drugs can interact with transporters, which are proteins that move substances across cell membranes
- block the action of transporters, reducing the movement of substances ( inhibit serotonin transporters)
- increase the activity of transporters, enhancing the movement of substances ( enhances uric acid transport)
Pharmacokinetics
Significance of drug half-life
- The time required for the concentration of a drug in the body to decrease by half
- Determines the frequency of drug administration
- Drugs with shorter half-lives require more frequent dosing to maintain therapeutic levels ()
- Drugs with longer half-lives can be administered less frequently ()
- achieved when the rate of drug elimination equals the rate of drug administration
- Typically reached after 4-5 half-lives
- Important for maintaining consistent therapeutic effects
Factors in drug effectiveness
- Absorption influenced by route of administration (oral, parenteral, topical), gastrointestinal factors (pH, motility, food intake), and drug formulation (tablets, capsules, liquids)
- affects the amount of drug that reaches systemic circulation
- affected by blood flow to tissues, protein binding, tissue permeability, and
- impacted by liver function, enzyme activity (cytochrome P450), and genetic variations in metabolic enzymes
- can significantly reduce oral drug bioavailability
- influenced by renal function, urine pH, and active tubular secretion and reabsorption
- Patient factors such as age, body weight and composition, comorbidities, and concomitant medications
Side effects vs adverse effects
- Side effects are predictable, dose-dependent effects that are not the primary therapeutic goal
- Often mild and tolerable (drowsiness, dry mouth, nausea)
- are unexpected, dose-independent effects that are harmful to the patient
- Can be severe and life-threatening (, liver , cardiac arrhythmias)
- Importance of monitoring to recognize and manage side effects and
- Adjusting dosage or switching medications when necessary
- Reporting adverse events to improve drug safety
Drug tolerance and toxicity
- Tolerance is decreased responsiveness to a drug after repeated exposure
- May require higher doses to achieve the same therapeutic effect
- Can develop with various drug classes (, )
- Mechanisms include receptor downregulation, enzyme induction, and compensatory physiological changes
- Toxicity refers to harmful effects resulting from excessive drug exposure
- Can occur due to overdose, accumulation, or drug interactions
- Dose-dependent toxicity: Severity increases with higher doses
- Idiosyncratic toxicity: Unpredictable, not directly related to dose
- Management involves supportive care, antidotes (when available), and discontinuation or dose adjustment of the offending drug
- relates drug efficacy to toxicity, guiding safe dosing
Drug Interactions
- can affect pharmacokinetics or
- May result in increased or decreased drug effects, toxicity, or treatment failure
- Common mechanisms include enzyme inhibition or induction, altered absorption, or competition for receptor binding
- Careful medication reconciliation and monitoring are essential to prevent adverse outcomes
Key Terms to Review (67)
Absorption: Absorption is the process by which a substance, such as a drug or nutrient, is taken up from the site of administration and enters the bloodstream or lymphatic system, making it available for distribution throughout the body. This term is crucial in understanding the pharmacokinetics and pharmacodynamics of drugs, as well as the functioning of the gastrointestinal system and the administration of various medications.
Acetaminophen: Acetaminophen is a widely used over-the-counter medication primarily used as an analgesic (pain reliever) and antipyretic (fever reducer). It is a key term in the context of drug classifications, pharmacokinetics, pain management, and non-opioid analgesics.
Action: Action in pharmacology refers to the mechanism by which a drug produces its effects on the body. It includes understanding how the drug interacts with cellular receptors and biochemical pathways.
Adverse effects: Adverse effects are unintended and harmful outcomes resulting from medication or other interventions. They can range from mild to severe and may require medical attention.
Adverse Effects: Adverse effects, also known as side effects, are unintended and undesirable consequences that can occur during or after the use of a drug or medication. These effects can range from mild discomfort to serious and potentially life-threatening conditions, and they are an important consideration in the context of drug classifications, pharmacokinetics, pharmacodynamics, drug administration, and the use of specific drug classes like angiotensin II receptor blockers (ARBs).
Affinity: Affinity is the strength of the interaction between a drug and its receptor. Higher affinity means the drug binds more tightly to its target receptor, often leading to greater potency.
Agonist: An agonist is a substance that binds to a receptor and activates it to produce a biological response. Agonists can be drugs or endogenous compounds like hormones.
Agonists: Agonists are substances that bind to and activate specific receptors in the body, mimicking the effects of the natural ligand or endogenous substance that normally binds to that receptor. They initiate a physiological response by triggering the receptor's signaling pathways.
Anaphylaxis: Anaphylaxis is a severe, life-threatening allergic reaction that can occur rapidly and requires immediate medical attention. It involves multiple organ systems and can lead to shock and death if not treated promptly.
Anaphylaxis: Anaphylaxis is a severe, whole-body allergic reaction that can be life-threatening. It occurs when the immune system overreacts to an allergen, triggering the rapid release of chemicals that cause widespread inflammation and impair breathing and blood circulation.
Antagonist: An antagonist is a substance that binds to a receptor but does not activate it, thereby blocking the action of agonists or endogenous substances. In pharmacology, antagonists are often used to inhibit the effects of other drugs or physiological processes.
Antagonists: Antagonists are substances that bind to and block the action of a receptor, preventing the binding and activation of that receptor by its normal agonist. They work by competitively or non-competitively inhibiting the receptor, reducing or eliminating the receptor's physiological response. Antagonists are crucial in the context of pharmacokinetics and pharmacodynamics as they can modulate the effects of drugs on the body.
Benzodiazepines: Benzodiazepines are a class of psychoactive drugs that have a calming and sedative effect on the central nervous system. They are commonly used as anxiolytics, sedative-hypnotics, and anticonvulsants, and are known for their ability to induce relaxation, reduce anxiety, and promote sleep.
Beta-adrenergic blockers: Beta-adrenergic blockers, also known as beta-blockers, are medications that reduce blood pressure by blocking the effects of adrenaline on beta receptors in the heart and blood vessels. They are used to treat various cardiovascular conditions including hypertension, angina, and dysrhythmias.
Bioavailability: Bioavailability refers to the degree and rate at which a drug or other substance is absorbed and becomes available at the site of action in the body. It is a crucial pharmacokinetic property that determines the effectiveness and safety of a medication.
Blood-Brain Barrier: The blood-brain barrier is a highly selective semipermeable membrane that separates the circulating blood from the brain and central nervous system (CNS). It acts as a gatekeeper, controlling the movement of substances between the bloodstream and the brain to protect the delicate neural tissue from harmful substances while allowing the passage of essential nutrients, oxygen, and other molecules required for proper brain function.
Channel Blockers: Channel blockers are a class of medications that work by inhibiting the movement of specific ions, such as calcium, sodium, or potassium, through specialized channels in the cell membrane. This disruption of ion flow can have various physiological effects, depending on the type of channel being blocked and the target tissue or organ.
Channel Openers: Channel openers are pharmacological agents that act by increasing the opening or activation of specific ion channels in the body, leading to altered physiological responses. These agents play a crucial role in the context of pharmacokinetics and pharmacodynamics, as they can influence the movement and effects of drugs within the body.
Cytochrome P450: Cytochrome P450 (CYP450) is a large family of enzymes found primarily in the liver that play a crucial role in the metabolism and biotransformation of a wide range of endogenous and exogenous compounds, including drugs, toxins, and other xenobiotics. These enzymes are responsible for the oxidative metabolism of many medications, making them a key factor in pharmacokinetics and drug interactions.
Cytochrome P450 2D6: Cytochrome P450 2D6 (CYP2D6) is an enzyme that metabolizes approximately 25% of commonly prescribed drugs, including many opioid agonists and antagonists. Its activity can vary widely among individuals due to genetic polymorphisms.
Dependence: Dependence is a condition in which a person requires a drug to function normally. Abrupt discontinuation can lead to withdrawal symptoms.
Distribution: Distribution is the process by which a drug is dispersed throughout the body’s fluids and tissues following administration. It determines the extent and rate at which active drug reaches its site of action.
Distribution: Distribution is the process by which a drug is transported throughout the body after absorption, moving from the bloodstream to the various tissues and organs. It is a crucial aspect of pharmacokinetics, determining how a drug is dispersed and made available to its site of action.
Drug Tolerance: Drug tolerance is a physiological state in which the body's response to a drug is diminished over time, requiring higher doses to achieve the same effect. This phenomenon is observed across various pharmacological contexts and is an important consideration in the management of drug therapy.
Drug-Drug Interactions: Drug-drug interactions occur when the effects of one drug are altered by the presence of another drug, leading to changes in the intended therapeutic outcome. These interactions can enhance or diminish the effectiveness of the drugs involved, and they are an important consideration in pharmacology, interdisciplinary teams, and nursing practice.
Duration of action: Duration of action is the length of time a drug continues to produce its therapeutic effect after administration. It is influenced by factors such as drug metabolism, excretion, and receptor binding.
Enzyme Inducers: Enzyme inducers are substances that can increase the production or activity of specific enzymes within the body, often leading to enhanced metabolism and clearance of certain drugs or other chemicals. This term is particularly relevant in the context of pharmacokinetics and pharmacodynamics, as enzyme induction can significantly impact the way drugs are absorbed, distributed, metabolized, and eliminated.
Enzyme Inhibitors: Enzyme inhibitors are substances that reduce or block the activity of enzymes, which are biological catalysts that accelerate chemical reactions in the body. They play a crucial role in pharmacokinetics and pharmacodynamics by modulating the effects of drugs and other substances on the body.
Excretion: Excretion is the process by which drugs and their metabolites are eliminated from the body, primarily through the kidneys in urine or through bile in feces. It is a crucial aspect of pharmacokinetics that influences drug duration and intensity.
Excretion: Excretion is the process by which the body eliminates waste products and other unwanted materials from the bloodstream and various tissues. It is a crucial aspect of pharmacokinetics and pharmacodynamics, as it determines the fate of drugs and their metabolites within the body.
First-pass effect: The first-pass effect is the rapid uptake and metabolism of an orally administered drug by the liver before it reaches systemic circulation. This process significantly reduces the bioavailability of the drug.
First-Pass Effect: The first-pass effect refers to the phenomenon where a drug, when administered orally, is partially metabolized by the liver before reaching the systemic circulation. This process can significantly reduce the amount of the active drug that ultimately reaches the target tissues, thereby impacting the drug's bioavailability and efficacy.
Fluoxetine: Fluoxetine is a selective serotonin reuptake inhibitor (SSRI) medication primarily used to treat depression, anxiety disorders, and other mental health conditions. It works by inhibiting the reuptake of the neurotransmitter serotonin, leading to increased serotonin levels in the brain and improved mood and emotional regulation.
Half-life: Half-life is the time required for the concentration of a drug in the bloodstream to reduce by half. It helps determine dosing intervals and duration of drug effects.
Half-Life: Half-life is a fundamental concept in pharmacology that describes the time it takes for the concentration or amount of a drug in the body to be reduced by half. It is a crucial factor in understanding the pharmacokinetics and pharmacodynamics of drugs, as well as their dosing and administration.
Intrinsic activity: Intrinsic activity refers to the ability of a drug to activate a receptor and produce a maximal biological response. It is a measure of the efficacy of a drug-receptor complex.
Ligand: A ligand is a molecule that binds to a specific site on a target protein, often a receptor, to induce a biological response. Ligands can be endogenous (originating within the body) or exogenous (originating outside the body, such as drugs).
Mechanism of action: Mechanism of action describes how a drug produces its effects in the body. It provides insight into the biochemical interactions at the molecular level.
Metabolism: Metabolism is the set of chemical reactions that occur within a living organism to maintain life. It includes processes for converting food to energy and eliminating metabolic wastes.
Metabolism: Metabolism is the sum of all chemical reactions that occur in the body to sustain life. It encompasses the processes of breaking down molecules to release energy (catabolism) as well as building up complex molecules from simpler ones (anabolism). Metabolism is a crucial concept in the context of pharmacology, interdisciplinary teams, and nursing practice, as it directly impacts how the body responds to and processes medications. Additionally, metabolism plays a central role in weight management, as it determines the rate at which the body burns calories and stores energy.
Minimum effective concentration (MEC): Minimum Effective Concentration (MEC) is the lowest concentration of a drug in the bloodstream that produces the desired therapeutic effect. It sets the baseline for effective dosing.
Morphine: Morphine is a powerful opioid analgesic medication primarily used for the relief of moderate to severe pain. As a prototype drug for the opioid agonist class, morphine's pharmacological properties and clinical applications are central to understanding key concepts in pharmacology, interdisciplinary teams, nursing practice, drug administration, pharmacokinetics, pharmacodynamics, and the management of opioid effects.
Naloxone: Naloxone is an opioid antagonist medication used to reverse the effects of opioid overdose. It works by binding to and blocking opioid receptors in the brain, preventing the action of opioid drugs and rapidly restoring normal respiration in individuals who have overdosed on opioids such as heroin, morphine, or prescription painkillers.
Onset of: Onset of action refers to the time it takes for a drug to produce a therapeutic effect after administration. This period varies depending on factors such as drug formulation, route of administration, and individual patient characteristics.
Opioids: Opioids are a class of drugs that act on the opioid receptors in the body, producing a wide range of effects including pain relief, sedation, and euphoria. They are commonly used in the management of acute and chronic pain, and their use is a critical aspect of pharmacology, interdisciplinary teams, and nursing practice.
Opioids are also classified as a type of drug prototype and their pharmacokinetics and pharmacodynamics are crucial in understanding their therapeutic and adverse effects. Additionally, the introduction and management of pain, a significant health concern, is closely tied to the use of opioid analgesics.
Partial agonists: Partial agonists are drugs that bind to and activate a receptor but produce a smaller effect compared to a full agonist. They can act as both agonists and antagonists depending on the presence of other substances.
Peak: Peak refers to the highest concentration of a drug in the bloodstream after administration. It indicates the point at which the medication is most effective.
Pharmacodynamics: Pharmacodynamics is the study of how drugs affect the body, including mechanisms of action and drug-receptor interactions. It examines the relationship between drug concentration and effect.
Pharmacodynamics: Pharmacodynamics is the study of the biochemical and physiological effects of drugs and their mechanisms of action within the body. It examines how drugs interact with the body's biological systems to produce their desired therapeutic effects or undesired side effects.
Pharmacokinetics: Pharmacokinetics is the study of how the body affects a drug, including the processes of absorption, distribution, metabolism, and elimination. It examines the movement of drugs within the body and how these processes impact the drug's concentration and duration of action.
Probenecid: Probenecid is a medication primarily used to treat gout and to aid in the excretion of certain drugs. It works by blocking the reabsorption of uric acid in the kidneys, leading to increased uric acid excretion and reduced blood uric acid levels. Probenecid also impacts the pharmacokinetics and pharmacodynamics of various drugs.
Receptor: Receptors are proteins on the surface of or within cells that bind to specific molecules, triggering a response in the cell. They play a crucial role in pharmacodynamics and homeostasis by mediating the effects of drugs and endogenous substances.
Receptor Affinity: Receptor affinity refers to the strength of the interaction between a drug or ligand and its target receptor. It is a measure of how tightly a drug or ligand binds to a specific receptor, which is a crucial factor in determining the drug's potency and effectiveness.
Rifampin: Rifampin is a broad-spectrum antibiotic that is widely used in the treatment of various bacterial infections, including tuberculosis. It is a potent inducer of the cytochrome P450 enzyme system, which can significantly impact the pharmacokinetics and pharmacodynamics of other drugs, as well as the management of conditions like calcium channel blocker therapy, anticoagulation, and phosphodiesterase 5 inhibitor usage.
Selective serotonin reuptake inhibitors (SSRIs): Selective serotonin reuptake inhibitors (SSRIs) are a class of drugs used primarily to treat depression by increasing serotonin levels in the brain. They work by blocking the reabsorption (reuptake) of serotonin into neurons, making more serotonin available.
Side effects: Side effects are unintended and often adverse outcomes that occur when a medication is administered. They can range from mild to severe and may affect patient compliance and safety.
Side Effects: Side effects are unintended and undesirable consequences that can occur when taking a medication or undergoing a medical treatment. They are distinct from the intended therapeutic effects and can range from mild to severe, sometimes even life-threatening.
SSRIs: SSRIs, or Selective Serotonin Reuptake Inhibitors, are a class of medications primarily used to treat depression and other mental health conditions. They work by selectively inhibiting the reuptake of the neurotransmitter serotonin, which is believed to play a crucial role in regulating mood, sleep, appetite, and other physiological processes.
Statins: Statins are a class of medications primarily used to lower cholesterol levels in the blood by inhibiting the enzyme HMG-CoA reductase, a key enzyme involved in the production of cholesterol. They play a crucial role in the management of cardiovascular health by reducing the risk of heart disease and stroke.
Steady-State Concentration: Steady-state concentration refers to the point at which the rate of drug absorption equals the rate of drug elimination, resulting in a consistent, stable concentration of the drug in the body. This term is particularly relevant in the context of pharmacokinetics and pharmacodynamics, as it describes the equilibrium state where the drug's effects can be predictably maintained over time.
Therapeutic index: Therapeutic index (TI) is the ratio of the toxic dose to the therapeutic dose of a drug, indicating its safety margin. A higher TI means a greater margin between effective and toxic doses, making the drug safer.
Therapeutic Index: The therapeutic index, also known as the therapeutic ratio, is a measure of the relative safety of a drug. It is the ratio between the dose that causes a toxic effect and the dose that produces the desired therapeutic effect. A higher therapeutic index indicates a wider margin of safety for a drug, meaning it has a lower risk of causing adverse effects when used at the recommended therapeutic dose.
Tolerance: Tolerance is the body's reduced response to a drug after repeated use, requiring higher doses to achieve the same effect. It involves pharmacokinetic and pharmacodynamic changes that diminish drug efficacy.
Toxicity: Toxicity is the degree to which a substance can harm humans or animals. It is a crucial factor in determining safe dosage levels for medications.
Toxicity: Toxicity refers to the degree to which a substance can cause harm or damage to an organism, tissue, or cell. It is a crucial concept in the fields of pharmacokinetics and pharmacodynamics, as it determines the safe and effective use of drugs and other chemicals within the body.
Transporter Enhancers: Transporter enhancers are compounds that increase the activity or expression of membrane transporters, which play a crucial role in the pharmacokinetics and pharmacodynamics of drugs. These enhancers can modulate the absorption, distribution, metabolism, and elimination of medications, ultimately impacting their therapeutic efficacy and safety.
Transporter Inhibitors: Transporter inhibitors are pharmacological agents that block the normal function of membrane transport proteins, known as transporters, which are responsible for the movement of various substances, including drugs, across cell membranes. These inhibitors can have significant implications for pharmacokinetics and pharmacodynamics by altering the absorption, distribution, metabolism, and elimination of drugs.